Kilroy Realty (KRC) Q1 2026 earnings review
Operational Inflection Masked by Messy GAAP Numbers
Kilroy's Q1 results present a stark contrast between operational momentum and headline financials. While the company posted a $19.3M net loss and a YoY FFO decline due to a $61.8M real estate impairment and the dilutive stabilization of the KOP 2 life science project, leasing velocity is accelerating. The 568,000 square feet leased marks the strongest Q1 since 2017. Management is aggressively monetizing older assets ($347M+ sold or contracted) to fund an opportunistic $72.7M share buyback and a new JV development. The underlying strength forced an upward revision to 2026 FFO and Same Property Cash NOI guidance, signaling the West Coast office recovery is real.
🐂 Bull Case
Management increased the 2026 FFO midpoint from $3.35 to $3.56 and flipped Same Property Cash NOI growth from negative to positive (0.25% to 1.25%). The operational bleeding has stopped.
Kilroy isn't just talking about cheap stock; they are acting. The company executed a $72.7M stock repurchase at $30.80/share, funded by selling non-core assets with high capital requirements.
🐻 Bear Case
Stabilized occupancy plummeted to 77.6% from 81.6% at the end of 2025. While largely driven by the mechanical addition of the under-leased KOP 2 project into the stabilized pool, it creates a significant optics hurdle and near-term earnings drag.
Despite high volume, cash rents on second-generation leases plummeted 16.8%. Landlords are still buying occupancy at the expense of rate.
⚖️ Verdict: 🟢
Bullish. The $61.8M impairment and KOP 2 dilution make the quarter look optically poor, but the upgrade to Same Property NOI guidance and robust 568k sq ft of leasing prove the core portfolio is stabilizing. The $72.7M share buyback shows management's conviction in their underlying value.
Key Themes
West Coast Leasing Momentum Continues
The company signed 568,000 square feet of leases, its highest Q1 volume in seven years. This builds on the 2.1 million square feet executed in 2025. The activity is heavily weighted toward new leases on vacant space (406,000 sq ft), proving that demand is absorbing actual vacancy, not just existing tenants shuffling paper.
Negative Spreads Contradict the 'Momentum' Narrative
Management frequently cites the 'healthiest level of office demand since 2019,' yet the pricing data tells a more painful story. Cash rents on second-generation leases signed during the quarter dropped a staggering 16.8%. The company attempts to soften this by noting that excluding space vacant for over 12 months, cash rents increased 5.2%. However, this confirms that moving older, stagnant inventory requires severe price concessions.
Strategic JV De-Risks New Development
Kilroy acquired an interest in 1900 Broadway in Redwood City and immediately signed a 145,000 sq ft lease with Cooley LLP, pre-leasing 58% of the 251,000 sq ft building. Entering this as a joint venture (expecting 97% ownership at 2030 delivery) limits near-term capital requirements while securing a blue-chip anchor in a prime submarket.
Aggressive Capital Returns via Dispositions
The company is executing perfectly on its capital recycling playbook. Kilroy sold $145.5M of non-core assets in San Diego (Sabre Springs and Del Mar) and contracted to sell $202M in Hollywood residential towers. They immediately redeployed $72.7M of these proceeds to repurchase 2.4 million shares at $30.80. Selling mature assets to buy back deeply discounted stock is highly accretive to FFO.
KOP 2 Financial Drag Materializes
The Kilroy Oyster Point Phase 2 (KOP 2) life science project officially entered the stabilized portfolio, violently dragging total occupancy down 400 basis points to 77.6%. As capitalization of interest and carry costs ceases, the project is now hitting the P&L directly, creating a mechanical headwind to FFO that will persist until the anchor leases (like the 280k sq ft UCSF deal) commence and start paying rent.
Accounting Relief for Flower Mart
Management updated its guidance to assume the continued capitalization of the Flower Mart project through December 2026, previously assumed to stop in June 2026. This accounting maneuver shelters the back half of 2026 from approximately $8M per quarter in operating and interest expenses, artificially boosting the updated FFO guidance.
Macro: AI-Driven Tech Demand Supporting the West Coast
The stabilization of Kilroy's leasing volume is heavily tethered to the broader macro recovery in the tech sector, specifically the rapid expansion of AI companies in the San Francisco Bay Area and Seattle. This macro tailwind is finally resulting in net positive absorption and justifying the company's reliance on its Spec Suite program to capture fast-moving tenant requirements.
Spec Suite Innovation Capturing Velocity
Kilroy's continued reliance on building out move-in ready 'Spec Suites' is proving critical for capturing modern tech and AI tenants. These companies often lack the internal resources or patience to manage 12-month buildouts and are willing to sign leases rapidly for premium, pre-built environments, pulling forward revenue commencement.
Other KPIs
Reversing drastically from a $39.0M profit a year ago. The entirety of this loss can be attributed to a sudden $61.8M non-cash impairment of real estate assets. While non-operating, it highlights the severe valuation markdowns still occurring in the office sector for specific legacy or non-core assets.
Decelerating. Dropped from $122.3M in 25Q1. The decline is driven by the cessation of interest capitalization at KOP 2, higher interest expenses ($38.5M vs $31.1M YoY), and the drag from assets sold during the quarter.
Guidance
Accelerating. Management raised the midpoint by $0.21 compared to their initial February guidance. This massive upward revision is driven by the delayed cessation of capitalization at the Flower Mart project (sheltering interest/OpEx), strong Q1 leasing velocity, and the accretive impact of the $72.7M share buyback.
Reversing. Upgraded from a prior range of (1.50%) to 0.00%. This is arguably the most important metric in the release: it proves that the core operating portfolio has officially bottomed and cash flows are growing again, aided by a $5.9M settlement income expected in Q2.
Accelerating. Up from the vague '+/- $300.0 million' given in February. With $347.5M already closed or contracted by April, the company has hit its baseline and has runway to sell up to $150M more to fund additional buybacks or deleveraging.
Accelerating. Increased from the previous $32.0 to $34.0 million guide. This purely reflects the decision to keep capitalizing the Flower Mart development through December 2026 rather than ceasing in June, sheltering current year FFO.
Key Questions
Flower Mart Capitalization Extension
The guidance update pushes the cessation of capitalization for Flower Mart from June to December 2026. Was this driven by a change in actual development activities/entitlement progress, or is it an accounting choice to protect 2026 FFO?
Pricing Power on Stagnant Vacancy
Cash rents on leases signed for space vacant for over 12 months were clearly deeply negative, dragging the total portfolio average to -16.8%. How much of the remaining vacancy has been empty for >12 months, and what level of concessions will be required to move it?
Cooley LLP JV Strategy
For the 1900 Broadway project, you opted for a Joint Venture structure despite securing a massive 145k sq ft anchor tenant in Cooley LLP. Why share the economics on a heavily de-risked asset rather than funding it entirely via disposition proceeds?
Pace of Share Repurchases
You repurchased $72.7M in stock this quarter. With guidance implying up to $150M in further dispositions this year, will buybacks remain the primary use of marginal capital, or are you stockpiling for a pipeline of acquisitions similar to Maple Plaza?